Evidence map›Paper›PMID 37713024›Full record

ArticleCancer causes & control : CCC2023

Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco.

Emily Bilenduke, Shacoria Anderson, Alison Brenner, Jessica Currier, Jan M Eberth, Jaron King, Stephanie R Land, Betsy C Risendal, Jackilen Shannon, Leeann N Siegel and 4 more

Abstract readLetter
In one paragraph

Article in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Reducing Stigma in Lung Cancer Screening: Co-Design of a Targeted Resource for Health Professionals in Australia.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  3. Lung cancer screening: are race- and risk-aware criteria needed?Journal of the National Cancer Institute · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emily BilendukeDepartment of Psychology, University of Colorado Denver, Denver, CO, USA. emily.bilenduke@ucdenver.edu.ORCID https://orcid.org/0000-0002-9790-9370
Shacoria AndersonDepartment of Behavioral, Social, and Health Education Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA.ORCID https://orcid.org/0000-0001-5672-2203
Alison BrennerDivision of General Medicine and Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0001-6421-9982
Jessica CurrierDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0002-2683-7912
Jan M EberthDepartment of Health Management and Policy, Drexel University, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0001-9500-4212
Jaron KingDepartment of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.ORCID https://orcid.org/0000-0002-1931-3336
Stephanie R LandTobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.ORCID https://orcid.org/0000-0002-1632-1437
Betsy C RisendalDepartment of Community and Behavioral Health, Colorado School of Public Health, Cancer Prevention and Control Program, University of Colorado Cancer Center, Aurora, CO, USA.ORCID https://orcid.org/0000-0002-2222-6399
Jackilen ShannonDivision of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-5377-9511
Leeann N SiegelTobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.ORCID https://orcid.org/0000-0002-3033-2474
Mary WangenCenter for Health Promotion and Disease Prevention, University of North Carolina, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0003-0780-1188
Austin R WatersLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0002-9947-8535
Whitney E ZahndDepartment of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, IA, USA.ORCID https://orcid.org/0000-0001-5174-8666
Jamie L StudtsDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Cancer Prevention and Control, University of Colorado Cancer Center, Aurora, CO, USA. jamie.studts@cuanschutz.edu.ORCID https://orcid.org/0000-0003-3922-3597

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Understanding Pathways to Earlier Diagnosis for Ovarian Cancer in North CarolinaU48DP006400 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S, LEEMAN, JENNIFER · 2018 to 2023
$9.3M
USC PRC Center and Core Research Project: National Implementation Study of the Faith, Activity, and Nutrition (FAN) ProgramU48DP006401 · DP · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI WILCOX, SARA · 2018 to 2023
$8.0M
University of Iowa Prevention Research Center for Rural HealthU48DP006389 · DP · UNIVERSITY OF IOWA · PI AFIFI, RIMA · 2018 to 2023
$7.4M
Rocky Mountain Prevention Research CenterU48DP006399 · DP · UNIVERSITY OF COLORADO DENVER · PI LEIFERMAN, JENN A, PUMA, JINI · 2018 to 2023
$6.9M
Cancer Care Quality Training ProgramT32CA116339 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ETHAN M. BASCH, Stephanie Brooke Wheeler · 2018 to 2026
$3.0M
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and CommunitiesR01CA254734 · NCI · UNIVERSITY OF COLORADO DENVER · PI Jerod L Stapleton, Jamie L Studts · 2021 to 2026
$2.4M
Integrated data analysis of determinants of low-dose CT screening for lung cancerR21CA234295 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EBERTH, JAN MARIE · 2020 to 2020
$314k
NCCDPHP CDC HHS U48 DP006389NCCDPHP CDC HHS U48 DP006399NCCDPHP CDC HHS U48 DP006400NCCDPHP CDC HHS U48 DP006401NCI NIH HHS P30 CA069533NCI NIH HHS P30CA069533NCI NIH HHS P30 CA086862NCI NIH HHS R01 CA254734NCI NIH HHS R21 CA234295NCI NIH HHS R21CA234295NCI NIH HHS T32 CA116339
6 · The paper itself

Abstract

purposeLung cancer is the leading cause of cancer death, but the advent of lung cancer screening using low-dose computed tomography offers a tremendous opportunity to improve lung cancer outcomes. Unfortunately, implementation of lung cancer screening has been hampered by substantial barriers and remains suboptimal. Specifically, the commentary emphasizes the intersectionality of smoking history and several important sociodemographic characteristics and identities that should inform lung cancer screening outreach and engagement efforts, including socioeconomic considerations (e.g., health insurance status), racial and ethnic identity, LGBTQ + identity, mental health history, military experience/veteran status, and geographic residence in addressing specific community risk factors and future interventions in efforts to make strides toward equitable lung cancer screening.

methodsMembers of the Equitable Implementation of Lung Cancer Screening Interest Group with the Cancer Prevention and Control Network (CPCRN) provide a critical commentary based on existing literature regarding smoking trends in the US and lung cancer screening uptake to propose opportunities to enhance implementation and support equitable distribution of the benefits of lung cancer screening.

conclusionThe present commentary utilizes information about historical trends in tobacco use to highlight opportunities for targeted outreach efforts to engage communities at high risk with information about the lung cancer screening opportunity. Future efforts toward equitable implementation of lung cancer screening should focus on multi-level implementation strategies that engage and work in concert with community partners to co-create approaches that leverage strengths and reduce barriers within specific communities to achieve the potential of lung cancer screening.

Indexed as

Lung NeoplasmsEarly Detection of CancerHumansRisk FactorsSmokingCommunity engagementEquityIntersectionalityLung cancer screeningTobacco use

Identifiers

PMID37713024
PMCPMC10689540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.